Barnes-Jewish Hospital Installs the Industry’s First General Purpose Digital SPECT/CT

St. Louis, MO – May 5, 2016 – Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose and monitor diseases at a functional level with GE Healthcare’s next-generation SPECT/CT system, Discovery NM/CT 670 CZT. The new SPECT/CT is the world’s first general purpose, ultra-high resolution SPECT/CT... Read more

GE Healthcare expands European capabilities to support accelerated biomanufacturing

CHALFONT ST. GILES, UK and PASCHING, AUSTRIA – 12 April 2016 – GE Healthcare’s Life Sciences business today announced that its European manufacturing and distribution site for sterile liquids has expanded its capabilities to include production of large volumes of buffers, process liquids and cell culture media, and launched a rapid production service for prototype... Read more

Charles Koontz Appointed President and CEO of GE Healthcare IT and GE Healthcare Chief Digital Officer

BARRINGTON, IL., March 9, 2016 — GE Healthcare (NYSE: GE) today announced the appointment of Charles Koontz as president and CEO of GE Healthcare IT and GE Healthcare Chief Digital Officer, effective March 14. Koontz succeeds Jan De Witte, who is leaving GE. Koontz joins GE from Computer Sciences Corp (CSC) and CSRA, where he was... Read more

GE Healthcare, FedDev Ontario commit CAD $40M for new CCRM-led centre to solve cell therapy manufacturing challenges

Chalfont St. Giles, UK and Toronto, Canada – 13 January 2016 – GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies in Toronto with an investment of CAD $40M from GE and FedDev Ontario.... Read more

BeiGene selects GE’s FlexFactory™ biomanufacturing platform for pilot cGMP production facility in China

CHALFONT ST. GILES, UK and BEIJING, CHINA – 16 December 2015 – GE Healthcare’s Life Sciences business and BeiGene, Ltd. today announced that BeiGene has selected GE’s FlexFactory™ biomanufacturing platform for its first current Good Manufacturing Practices (cGMP) biomanufacturing facility in Suzhou, China.  Currently under construction, the facility is expected to be operational by 2017.... Read more

NBA and GE Healthcare Leadership Meet on Injury Prevention, Diagnosis and Treatment

WAUWATOSA, Wis., Dec. 7, 2015 – The National Basketball Association (NBA) and GE Healthcare (NYSE: GE) today conducted a successful meeting at GE’s Wisconsin offices to discuss the progress of their research collaboration.  The partnership, which commenced in July, promotes sports medicine research to benefit not only NBA players but athletes of all levels.  Today’s... Read more

GE Healthcare Life Sciences strengthens business resilience with ISO 22301 business continuity accreditation for chromatography media

CHALFONT ST. GILES, UK – 3 December 2015 – GE Healthcare’s Life Sciences business today announced that its chromatography media manufacturing facility and supporting functions in Uppsala, Sweden have been certified to ISO 22301, the international standard for business continuity management systems.  Chromatography medium is a key component in the production of biopharmaceuticals such as... Read more

GE Healthcare to Connect 500,000 Imaging Machines with Announcement of GE Health Cloud and Apps

CHICAGO, Ill. – November 29, 2015 – The GE Health Cloud[1] was unveiled today at the 101st annual Radiological Society of North America (RSNA) meeting in Chicago. Designed exclusively for the healthcare industry, the new cloud ecosystem and its applications will connect radiologists and clinicians to speed, efficiency and collaboration across care pathways and multidisciplinary... Read more

GE Healthcare and the National Basketball Association seek proposals to accelerate research on the prevention, diagnosis and treatment of tendinopathy

WAUKESHA, WI, and NEW YORK, NY – November 17, 2015 – GE Healthcare (NYSE: GE) and the National Basketball Association (NBA) today launched a call for research proposals for tendinopathy. The call for proposals is the first as part of a collaboration between the NBA and GE Healthcare to help research the prevention, diagnosis and... Read more

OHSU, GE Healthcare team up to explore new frontiers in health care innovation

PORTLAND, Ore. – Oregon Health & Science University and GE Healthcare have signed a memorandum of understanding to develop collaborative research programs in cardiovascular medicine, imaging and big data research. The research programs are aimed at bringing together OHSU’s clinical expertise with GE Healthcare’s technology prowess to answer fundamental questions in biology and medicine.  ... Read more